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Treatment Modalities in Pediatric Depression
Katie McNally RN, BSN
Instructor: Dr. Linda Samia PhD, RN, CNL

Purpose
The purpose of this evidence-based project is to
answer the following question: In pediatric patients
with Major Depressive Disorder (MDD), how does
combination treatment with a Selective Serotonin
Reuptake Inhibitor (SSRI) and cognitive behavior
therapy (CBT) affect symptoms of depression, when
compared with using only an SSRI?

Background
• Pediatric MDD 11.7%,6 increasing >50% by 2020, will
be in top 5 causes of mortality and morbidity in
children.4
• Common symptoms: chronic pain, headaches, risky
sexual behaviors, STIs, poor eating/sleeping;
Increased health costs; poor performance in school
and relationships.1,2,7
• Suicide 3rd leading cause of death for teens.6
• Many PCPs uncomfortable treating pediatric patients,
3,6
especially very young (<12 years old). Only 1 in 5
children with MDD receive appropriate treatment.7
• Clinical practice guidelines lacking in pediatric
population; metabolism, response to medications in
the brain & developmental processes not well
understood and are different than adults; treatment
has been very conservative.6

Evidence Synthesis
• Depression scores on standardized tests
decreased with combo therapy – not statistically
significant, however.
• Suicidality decreased significantly in both
groups, showing positive effect of SSRI with or
without CBT.
• Time to remission of symptoms not significantly
less with combo therapy, however rate of
relapse was much lower, showing a clinical
significance in adding CBT to treatment.

Translation to Practice

• Education and counseling on depression.
• Refer to social worker or therapist if needed.
Assess for safety, potential for self-harm, follow
up in 2-4 months.
• Start low dose SSRI. Titrate up to min effective
dose & continue for 6-12 months after remission
of symptoms..3
• CBT: provide education & treatment plan for
MDD, teach relaxation, coping & problemsolving, encourage goal-setting, & increase
engagement and cooperation, decrease of
symptoms.7
• Considerations – children and teens can be
especially difficult to treat due to lack of
knowledge and understanding of importance of
these treatments, adherence issues. Obtain
parental support for CBT & assist with
Multiple databases searched: CINAHL, MEDLINE, and
accessibility. Arrange so social impact as low as
a general medical database search. Keywords used
possible for the patient – not during school time
include “pediatric,” “depression,” “MDD,” “SSRI,”
or interfering with social activities.
“CBI,” “non-pharmacological,” “psychotherapy,” and
“nutrition.” Four studies were included with level of
evidence and validity generally average to high
quality.

Evidence Appraisal

Proposed Evaluation
• Follow up 4wks, 6mo, and 1yr –
instability/adherence issues require closer
management.
• Standardized testing to evaluate results include:
Beck’s Depression Inventory (BDI) - selfreported symptoms: dysphoria, anhedonia,
suicidality, sleep dysfunction, cognitive
2
function, and appetite changes.
Children’s Global Assessment Scale –
Revised (CGAS-R) - Provider-reported
symptoms 5
Child-Behavior Checklist (CBCL) – Parent
checklist on behavior, problem-solving, and
1
somatic symptoms.

Conclusion
• CBT should be considered as an effective
treatment in all forms and severities of
depression.
• SSRI treatment for moderate-severe depression.
• Regular evaluation of efficacy of treatments and
assessment for further symptoms is critical to
ensure remission and prevent relapse.
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